Carolina Sturm-Pellanda Selected Research

taspoglutide

1/2019	Assessment of Drug-Drug Interactions between Taspoglutide, a Glucagon-Like Peptide-1 Agonist, and Drugs Commonly Used in Type 2 Diabetes Mellitus: Results of Five Phase I Trials.
11/2015	Subcutaneous Bioavailability of Taspoglutide at 3 Different Injection Sites in Healthy Overweight/Obese Subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carolina Sturm-Pellanda Research Topics

Disease

3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 11/2015
1	Central Nervous System Neoplasms 01/2023
1	Body Weight (Weight, Body) 12/2018
1	Nausea 11/2015
1	Vomiting 11/2015
1	Weight Loss (Weight Reduction) 11/2015
1	Overweight 11/2015

Drug/Important Bio-Agent (IBA)

3	alectinibIBA 01/2023 - 01/2017
2	taspoglutideIBA 01/2019 - 11/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 12/2018
1	CrizotinibIBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2015

Therapy/Procedure

1	Subcutaneous Injections 11/2015